Most Popular News
January 23, 2018

Two studies leveraging highly novel approaches show considerable merit for enhancing colorectal cancerscreening and improving the efficiency of surveillance.

Read more
January 23, 2018

A General Session held January 20 during the 2018 Gastrointestinal Cancers Symposium provided a comprehensive overview of early-onset CRC, including results of a study focused on the age distribution of tumor gene expression in patients with stage II/III colon cancer.

Read more

January 20, 2018

The phase III CELESTIAL trial met its primary endpoint by demonstrating a survival advantage with cabozantinib in patients with advanced hepatocellular carcinoma (HCC) that progressed following prior systemic therapy.

Read more

January 20, 2018

Use of the oral fluoropyrimidine-based chemotherapy S-1 in combination with gemcitabine yielded similar efficacy and a more favorable and convenient tolerability profile versus cisplatin and gemcitabine in patients with advanced biliary tract cancer.

Read more
January 20, 2018

Results of the randomized controlled TACTICS trial demonstrate that transcatheter arterial chemoembolization (TACE) in combination with sorafenib significantly improved progression-free survival (PFS) in patients with unresectable hepatocellular carcinoma (HCC), as compared with TACE alone.

Read more

January 20, 2018

Five important talks delivered the morning of January 19 during the 2018 Gastrointestinal Cancers Symposium covered diverse topics that provide insight into future diagnostic, management, and research directions in hepatocellular carcinoma

Read more

January 19, 2018

Results of the global, randomized, double-blind, placebo-controlled, phase III RAINFALL trial established the statistical benefit of ramucirumab added to standard chemotherapy for patients with previously untreated metastatic gastric or gastroesophageal junction adenocarcinoma.

Read more

January 19, 2018

Two studies that investigated the ways in which neoadjuvant chemoradiation therapy is delivered before surgery and how different parameters influence survival outcomes raise some questions and suggest that CRT may exert unintended consequences.

Read more

January 19, 2018

Final results of the randomized phase II CatuNeo trial conducted in patients with peritoneal carcinomatosis from gastric cancer provide mixed results.

Read more

January 19, 2018

Several presentations delivered on January 18 offered a look at how different regions identify and manage early gastric cancer around the world.

Read more
January 11, 2018

The European Society for Medical Oncology 2017 World Congress featured an array of new research and important discussions of clinical practice considerations for gastrointestinal malignancies.

Read more
January 11, 2018

Women in oncology aren’t ascending the leadership ladder at rates anywhere close to their male counterparts—and ASCO wants to fix that.

Read more
January 11, 2018

ASCO has announced that the first three practices in Spain have received Quality Oncology Practice Initiative Certification through the QOPI Certification Program. 

Read more
January 11, 2018

Dr. Jalil Ali and Dr. Layth Mula-Hussain are two of the oncologists determined to revive cancer care progress in Iraq.

Read more
January 11, 2018

The ASCO clinical practice guideline stresses that health care providers need to initiate the discussion about sexual function with their patients as early as possible in the treatment paradigm.

Read more
January 11, 2018

CancerLinQ LLC, a wholly owned nonprofit subsidiary of ASCO, has signed formal collaboration agreements with seven other nonprofit associations and two federal agencies.

Read more

January 11, 2018

Dr. Benjamin L. Solomon and Dr. Ignacio Garrido-Laguna discuss treatment strategies for pancreatic ductal adenocarcinoma.

Read more
January 11, 2018

Dr. Flavio G. Rocha reviews liver-directed therapy for advanced intrahepatic cholangiocarcinoma, which can be difficult to manage because of several factors including late diagnosis, early metastatic spread, and potential for liver dysfunction. 

Read more

January 11, 2018

Dr. Davendra P. S. Sohal discusses the management of metastatic pancreatic cancer, specifically the advances made since ASCO issued guidelines in 2016 for management of metastatic pancreatic cancer and the future direction for treatment.

Read more

January 11, 2018

Dr. Shailesh V. Shrikhande of the Tata Memorial Centre, in Mumbai, India, discusses gastrointestinal cancers in India and how the steps being taken to address them align with the theme of this year's Symposium.

Read more